References
  1. Singh, K., et al., Mst1/2 kinases restrain transformation in a novel transgenic model of Ras driven non-small cell lung cancer.Oncogene, 2019: p. 1-13.
  2. Raniszewska, A., et al., PD-L1 expression on lung cancer stem cells in metastatic lymph nodes aspirates. Stem Cell Reviews and Reports, 2019. 15 (2): p. 324-330.
  3. Lara-Guerra, H. and J.A. Roth, Gene therapy for lung cancer.Critical Reviews™ in Oncogenesis, 2016. 21 (1-2).
  4. Aktaş, O.N., et al., Role of natural killer cells in lung cancer. Journal of cancer research and clinical oncology, 2018.144 (6): p. 997-1003.
  5. Degos, C., et al., Endometrial tumor microenvironment alters human NK cell recruitment, and resident NK cell phenotype and function. Frontiers in immunology, 2019. 10 : p. 877.
  6. Li, Y., et al., M860, a Monoclonal Antibody against Human Lactoferrin, Enhances Tumoricidal Activity of Low Dosage Lactoferrin via Granzyme B Induction. Molecules, 2019. 24 (20): p. 3640.
  7. Barrett, C.S., A.C. Millena, and S.A. Khan, TGF-beta Effects on Prostate Cancer Cell Migration and Invasion Require FosB. Prostate, 2017. 77 (1): p. 72-81.
  8. Caramori, G., et al., Molecular links between COPD and lung cancer: new targets for drug discovery? Expert opinion on therapeutic targets, 2019. 23 (6): p. 539-553.
  9. Chollat-Namy, M., et al., The pharmalogical reactivation of p53 function improves breast tumor cell lysis by granzyme B and NK cells through induction of autophagy. Cell death & disease, 2019.10 (10): p. 1-20.
  10. Hassan, I.A., et al., Low production of granzyme B by Cytotoxic T cells and Natural killer cells associated with the increased levels of cytokines and chemokine’s in early diagnostic lung cancer patients. International Journal of Cancer and Biomedical Research, 2020.
  11. Travis, W., et al., ES12. 05 Impact of STAS in Lung Cancer Staging. Journal of Thoracic Oncology, 2019. 14 (10): p. S45.
  12. Seeligmüller, N., Faster Isolation of PBMC Using Ficoll-Paque. Plus in the Eppendorf® Centrifuge 5920 R . 2016, Application Note.
  13. Adan, A., et al., Flow cytometry: basic principles and applications. Critical reviews in biotechnology, 2017.37 (2): p. 163-176.
  14. Green, K.J., D.G. Rowbottom, and L.T. Mackinnon, Exercise and T-lymphocyte function: a comparison of proliferation in PBMC and NK cell-depleted PBMC culture. Journal of Applied Physiology, 2002.92 (6): p. 2390-2395.
  15. Datta, S.C. and M.R. Opp, Lipopolysaccharide-induced increases in cytokines in discrete mouse brain regions are detectable using Luminex xMAP® technology. Journal of neuroscience methods, 2008.175 (1): p. 119-124.
  16. Lin, X.-R., et al., CIK cell-based delivery of recombinant adenovirus KGHV500 carrying the anti-p21Ras scFv gene enhances the anti-tumor effect and safety in lung cancer. Journal of cancer research and clinical oncology, 2019. 145 (5): p. 1123-1132.
  17. Jiang, X., et al., Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape. Molecular cancer, 2019.18 (1): p. 1-17.
  18. Huang, J.Y., et al., Circulating markers of cellular immune activation in prediagnostic blood sample and lung cancer risk in the Lung Cancer Cohort Consortium (LC3). International journal of cancer, 2019.
  19. Giraldo, N.A., et al., The clinical role of the TME in solid cancer. British journal of cancer, 2019. 120 (1): p. 45-53.
  20. Butler, S.J., et al., Prevalence of lung cancer in chronic obstructive pulmonary disease: A systematic review. Respiratory Medicine: X, 2019: p. 100003.
  21. Yan, C., et al., Antibiotics and immunotherapy in gastrointestinal tumors: Friend or foe? World Journal of Clinical Cases, 2019. 7 (11): p. 1253.
  22. Fu, Y., et al., LncRNA CASC11 promotes TGF-β1, increases cancer cell stemness and predicts postoperative survival in small cell lung cancer. Gene, 2019. 704 : p. 91-96.
  23. Diaz-Montero, C.M., et al., Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy. Cancer immunology, immunotherapy, 2009. 58 (1): p. 49-59.
  24. Alghamri, M.S., et al., Functional assay to assess T-cell inhibitory properties of myeloid derived suppressor cells (MDSCs) isolated from the tumor microenvironment of murine glioma models , inMethods in Enzymology . 2020, Elsevier. p. 215-228.
  25. Cechova, K., et al., Up-regulation of mu-, delta- and kappa-opioid receptors in concanavalin A-stimulated rat spleen lymphocytes. J Neuroimmunol, 2018. 321 : p. 12-23.
  26. Turajlic, S., et al., Tracking cancer evolution reveals constrained routes to metastases: TRACERx renal. Cell, 2018.173 (3): p. 581-594. e12.
  27. De, U., et al., Plumbagin from a tropical pitcher plant (Nepenthes alata Blanco) induces apoptotic cell death via a p53-dependent pathway in MCF-7 human breast cancer cells. Food and chemical toxicology, 2019. 123 : p. 492-500.
  28. Shimojima, Y., et al., Characteristics of circulating natural killer cells and their interferon-γ production in active adult-onset Still disease. The Journal of rheumatology, 2019. 46 (10): p. 1268-1276.
  29. Wang, H., et al., Tumor-derived soluble MICs impair CD3+ CD56+ NKT-like cell cytotoxicity in cancer patients. Immunology letters, 2008. 120 (1-2): p. 65-71.
  30. Hu, Q., et al., Role of ALDH1A1 and HTRA2 expression in CCL2/CCR2-mediated breast cancer cell growth and invasion. Biology open, 2019. 8 (7): p. bio040873.
  31. Saad, M.I., et al., ADAM17 selectively activates the IL‐6 trans‐signaling/ERK MAPK axis in KRAS‐addicted lung cancer. EMBO molecular medicine, 2019. 11 (4).
  32. Donnenberg, A.D., J.D. Luketich, and V.S. Donnenberg, Secretome of pleural effusions associated with non-small cell lung cancer (NSCLC) and malignant mesothelioma: therapeutic implications.Oncotarget, 2019. 10 (60): p. 6456.